Abstract
Background: Healthcare-Acquired Infections (HAIs) are serious healthcare complications affecting hospital stay, in-hospital mortality, and costs. Root cause analysis has identified the inappropriate use of antibiotics as the main causative factor in the expansion of multi-drug-resistant organisms (MDRO) in our hospital. An Antimicrobial Stewardship (AMS) program was implemented to optimize antibiotic use, limit the development of resistance, improve therapeutic efficacy and clinical outcomes, and reduce costs. Methods: The stewardship strategies were: antimicrobial oversight on “critical” antibiotics; the development of hospital guidelines on antibiotic selection with the production of a consensus document; the implementation of clinical and management control algorithms with visual impact and Business Intelligence methods; training and updating; and the monitoring of outcome measures and process indicators. Results: Clinical outcomes: length of stay reduced by 0.23 days, hospital readmission/first month rates decreased by 19%, and mortality for infections reduced by 8.8%. Microbiological Outcomes: Clostridium Difficile colitis incidence reduced by 9.1%.Economic Outcomes: Reduction in antimicrobial costs by 35% on average fee/discharged patient. Conclusions: The systematic application of the AMS program in a small hospital led to multiple improvements in clinical, microbiological, and economic outcome measures. The analysis of the core indicators for our hospital AMS program showed a significant adherence to the model and hospital recommendations.
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference44 articles.
1. Emerging Infections Program Hospital Prevalence Survey Team. Changes in Prevalence of Health Care-Associated Infections in U.S. Hospitals;Magill;N. Engl. J. Med.,2018
2. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: Results from two European point prevalence surveys, 2016 to 2017;Suetens;Euro Surveill.,2018
3. World Health Organization (WHO) (2022, September 28). Global Report on Infection Prevention and Control. Executive Summary. Available online: https://cdn.who.int/media/docs/default-source/integrated-health-services-(ihs)/ipc/ipc-global-report/who_ipc_global-report_executive-summary.pdf.
4. A systematic review and meta-analysis on the effects of antibiotic consumption on antibiotic resistance;Bell;BMC Infect. Dis.,2014
5. Bakhit, M., Hoffmann, T., Scott, A.M., Beller, E., Rathbone, J., and Del Mar, C. (2018). Resistance decay in individuals after antibiotic exposure in primary care: A systematic review and meta-analysis. BMC Med., 16.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献